Charles Schwab’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $342M | Buy |
650,429
+40,212
| +7% | +$22.6M | 0.05% | 317 |
|
|
2026
Q1 | $343M | Buy |
610,217
+20,155
| +3% | +$12.9M | 0.05% | 285 |
|
|
2025
Q4 | $399M | Buy |
590,062
+14,132
| +2% | +$9.62M | 0.06% | 249 |
|
|
2025
Q3 | $368M | Buy |
575,930
+19,368
| +3% | +$11.8M | 0.06% | 272 |
|
|
2025
Q2 | $299M | Buy |
556,562
+4,616
| +0.8% | +$2.21M | 0.05% | 297 |
|
|
2025
Q1 | $232M | Buy |
551,946
+20,254
| +4% | +$8.79M | 0.04% | 341 |
|
|
2024
Q4 | $220M | Buy |
531,692
+16,213
| +3% | +$7.11M | 0.04% | 358 |
|
|
2024
Q3 | $260M | Sell |
515,479
-4,770
| -0.9% | -$2.32M | 0.05% | 304 |
|
|
2024
Q2 | $253M | Buy |
520,249
+18,663
| +4% | +$9.37M | 0.05% | 313 |
|
|
2024
Q1 | $271M | Buy |
501,586
+24,787
| +5% | +$13.5M | 0.06% | 270 |
|
|
2023
Q4 | $265M | Buy |
476,799
+14,264
| +3% | +$6.7M | 0.07% | 259 |
|
|
2023
Q3 | $202M | Buy |
462,535
+5,044
| +1% | +$2.52M | 0.06% | 298 |
|
|
2023
Q2 | $230M | Buy |
457,491
+2,509
| +0.6% | +$1.2M | 0.07% | 257 |
|
|
2023
Q1 | $228M | Buy |
454,982
+8,611
| +2% | +$4.12M | 0.07% | 249 |
|
|
2022
Q4 | $182M | Buy |
446,371
+12,904
| +3% | +$5.01M | 0.06% | 304 |
|
|
2022
Q3 | $141M | Sell |
433,467
-14,027
| -3% | -$5.15M | 0.05% | 342 |
|
|
2022
Q2 | $157M | Buy |
447,494
+4,053
| +0.9% | +$1.65M | 0.05% | 316 |
|
|
2022
Q1 | $243M | Sell |
443,441
-6,550
| -1% | -$3.45M | 0.07% | 253 |
|
|
2021
Q4 | $296M | Buy |
449,991
+8,468
| +2% | +$5.32M | 0.09% | 201 |
|
|
2021
Q3 | $275M | Sell |
441,523
-6,253
| -1% | -$4.2M | 0.09% | 196 |
|
|
2021
Q2 | $283M | Buy |
447,776
+22,508
| +5% | +$12.4M | 0.09% | 188 |
|
|
2021
Q1 | $208M | Sell |
425,268
-25,521
| -6% | -$12.8M | 0.08% | 230 |
|
|
2020
Q4 | $225M | Buy |
450,789
+21,424
| +5% | +$9.59M | 0.09% | 204 |
|
|
2020
Q3 | $169M | Buy |
429,365
+37,161
| +9% | +$13.7M | 0.08% | 226 |
|
|
2020
Q2 | $129M | Sell |
392,204
-28,091
| -7% | -$8.13M | 0.06% | 275 |
|
|
2020
Q1 | $102M | Buy |
420,295
+16,156
| +4% | +$4.22M | 0.06% | 284 |
|
|
2019
Q4 | $106M | Buy |
404,139
+6,811
| +2% | +$1.79M | 0.06% | 308 |
|
|
2019
Q3 | $108M | Buy |
397,328
+9,553
| +2% | +$2.66M | 0.06% | 286 |
|
|
2019
Q2 | $107M | Sell |
387,775
-4,316
| -1% | -$1.06M | 0.06% | 277 |
|
|
2019
Q1 | $87.7M | Buy |
392,091
+3,450
| +0.9% | +$712K | 0.06% | 320 |
|
|
2018
Q4 | $72.3M | Buy |
388,641
+20,836
| +6% | +$4.27M | 0.06% | 320 |
|
|
2018
Q3 | $91.8M | Buy |
367,805
+10,933
| +3% | +$2.65M | 0.06% | 291 |
|
|
2018
Q2 | $77.8M | Buy |
356,872
+34,590
| +11% | +$7.13M | 0.06% | 334 |
|
|
2018
Q1 | $61.7M | Sell |
322,282
-738
| -0.2% | -$136K | 0.05% | 375 |
|
|
2017
Q4 | $50.5M | Sell |
323,020
-57,268
| -15% | -$9.01M | 0.04% | 447 |
|
|
2017
Q3 | $59.1M | Sell |
380,288
-223,292
| -37% | -$35.3M | 0.05% | 343 |
|
|
2017
Q2 | $97.4M | Buy |
603,580
+228
| +0% | +$37K | 0.09% | 215 |
|
|
2017
Q1 | $93.3M | Buy |
603,352
+114,191
| +23% | +$15.7M | 0.09% | 207 |
|
|
2016
Q4 | $57.4M | Buy |
489,161
+155,497
| +47% | +$17.7M | 0.06% | 301 |
|
|
2016
Q3 | $37.6M | Buy |
333,664
+77,713
| +30% | +$8.19M | 0.04% | 409 |
|
|
2016
Q2 | $23.8M | Sell |
255,951
-14,794
| -5% | -$1.27M | 0.03% | 554 |
|
|
2016
Q1 | $21.2M | Buy |
270,745
+9,732
| +4% | +$701K | 0.03% | 585 |
|
|
2015
Q4 | $19M | Buy |
261,013
+17,679
| +7% | +$1.26M | 0.03% | 621 |
|
|
2015
Q3 | $18.1M | Buy |
243,334
+1,823
| +0.8% | +$131K | 0.03% | 595 |
|
|
2015
Q2 | $15.5M | Buy |
241,511
+20,903
| +9% | +$1.45M | 0.02% | 708 |
|
|
2015
Q1 | $17M | Buy |
220,608
+24,472
| +12% | +$1.9M | 0.02% | 637 |
|
|
2014
Q4 | $14.5M | Buy |
196,136
+4,676
| +2% | +$328K | 0.02% | 654 |
|
|
2014
Q3 | $11.3M | Buy |
191,460
+4,232
| +2% | +$268K | 0.02% | 725 |
|
|
2014
Q2 | $12.5M | Buy |
187,228
+7,870
| +4% | +$500K | 0.02% | 675 |
|
|
2014
Q1 | $10.9M | Buy |
179,358
+10,554
| +6% | +$629K | 0.02% | 741 |
|
|
2013
Q4 | $8.98M | Buy |
168,804
+15,536
| +10% | +$818K | 0.02% | 796 |
|
|
2013
Q3 | $7.87M | Buy |
153,268
+13,304
| +10% | +$639K | 0.02% | 791 |
|
|
2013
Q2 | $6.35M | Buy |
+139,964
| New | +$6.12M | 0.01% | 849 |
|
Other funds holding IDXX
Charles Schwab's IDXX Position: Q2 2026 in Review
Charles Schwab increased its Idexx Laboratories (IDXX) stake by 6.6% in Q2 2026, buying an estimated $22.6M and bringing the position to 650,429 shares worth $342M. The position accounts for 0.05% of the portfolio, ranked #317.
Charles Schwab first reported a position in IDXX in Q2 2013 and has held it in 53 quarters since. The position peaked at $399M in Q4 2025. 1,296 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.
- Charles Schwab held 650,429 shares of Idexx Laboratories worth $342M as of Q2 2026.
- Charles Schwab bought 40,212 Idexx Laboratories shares in Q2 2026, an estimated $22.6M.
- Idexx Laboratories made up 0.05% of Charles Schwab's portfolio in Q2 2026, its #317 holding.
- Charles Schwab first reported a position in Idexx Laboratories in Q2 2013 and has held it in 53 quarters since.
- Charles Schwab's Idexx Laboratories position peaked at $399M in Q4 2025.
- 1,296 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.
Based on Charles Schwab's 13F filing for Q2 2026, filed 14 Aug 2026.